Butyrate and HMG-CoA reductase inhibitors in ulcerative colitis

Butyrate and HMG-CoA reductase inhibitors in ulcerative colitis

Bibliographic Details
Main Author:	McKay, Damian
Published:	Queen's University Belfast 2010
Subjects:	615
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.528019

Similar Items

Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01)

The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01)

HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
by: H J Harwood, Jr, et al.
Published: (1982-07-01)

The role of HMG-CoA reductase inhibitors in cardiovascular risk reduction
by: McIntyre, Christine
Published: (2004)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
by: DANIEL M. DUDA-SEIMAN, et al.
Published: (2011-01-01)

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
by: Xuemei Li, et al.
Published: (2013-01-01)

The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor Cells
by: Kusuyama Takanori, et al.
Published: (2006-01-01)

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
by: Jobin Jean, et al.
Published: (2004-05-01)

Determination of HMG-CoA reductase inhibitors by micellar electrokinetic chromatography
by: Mircia Eleonora, et al.
Published: (2016-06-01)

Pharmacogenetic and environmental determinants of response to HMG-CoA reductase inhibitors.
Published: (2007)

Therapeutic Interchange Evaluation of HMG-CoA Reductase Inhibitors in Patients with Dyslipidemia
by: Lin, Hong-Yun, et al.
Published: (2006)

Discovering Human HMG-CoA Reductase Inhibitors as Potential Hypocholesterolemia Agents
by: Shin-Hung Lin, et al.
Published: (2014)

Activation of HMG-CoA reductase by microsomal phosphatase
by: K R Feingold, et al.
Published: (1983-03-01)

Regulation of HMG-CoA reductase activity in plants.
by: B A Stermer, et al.
Published: (1994-07-01)

Effects of HMG-CoA Reductase Inhibitors (Statins) On Bone Mineral Density and Metabolism
by: Nehir Samancı, et al.
Published: (2004-06-01)

Identification of HMG-CoA Reductase Inhibitor Active Compound in Medicinal Forest Plants
by: Shelly Rahmania, et al.
Published: (2017-08-01)

Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation
by: Vera Lúcia Portal, et al.
Published: (2003-02-01)

Study of the novel anti-cancer mechanisms of thalidomide and HMG-CoA reductase inhibitors
by: Yi-Chu Lin, et al.
Published: (2008)

An Evaluation of HMG-CoA Reductase Inhibitor Drug-Drug Interactions for Quality in the Literature
by: Green, Nathaniel, et al.
Published: (2012)

A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase
by: Paula Mihaljević-Jurič, et al.
Published: (2021-06-01)

Occupancy and function of the hepatic HMG-CoA reductase promoter
by: Lagor, William Raymond
Published: (2006)

The Regulation of HMG-CoA Reductase by Enzyme-Lipid Interactions
by: Smith, Vana L.
Published: (1981)

HMG CoA reductase of intestinal mucosa and liver of the rat
by: S. Shefer, et al.
Published: (1972-05-01)

HMG-CoA reductase is not the site of the primary defect in phytosterolemia
by: G.M.B. Berger, et al.
Published: (1998-05-01)

HMG-CoA reductase inhibitors suppress EGF-induced migration in anaplastic thyroid carcinoma
by: Jr-Jiun Liu, et al.
Published: (2014)

The HMG-CoA Reductase Inhibitor Activities of Soy Protein Hydrolysates from Papain Hydrolysis
by: Sandra Hermanto, et al.
Published: (2021-07-01)

Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.
by: Richard D Moore, et al.
Published: (2011-01-01)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
by: Suetonia C. Palmer, et al.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
by: Suetonia C. Palmer, et al.

Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research
by: Hun-Sung Kim, et al.
Published: (2017-02-01)

Class II HMG-CoA Reductase Inhibitors targeting Methicillin-Resistant Staphylococcus pseudintermedius
by: Waleed Younis, et al.
Published: (2017-01-01)

Atherogenic Impact of Homocysteine: Can HMG-CoA Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?
by: Nikolic Tamara, et al.
Published: (2019-06-01)

Effect of HMG CoA reductase inhibitor on VEGF secretion of human retinal pigment epithelium
by: Chi-Wu Chang, et al.
Published: (2007)

HMG-CoA Reductase Inhibitors Act Synergistically with UCN-01 Through RAS Inhibition
by: Khanna, Payal
Published: (2006)

HMG-CoA reductase inhibitors perturb fatty acid metabolism and induce peroxisomes in keratinocytes.
by: ML Williams, et al.
Published: (1992-02-01)

Evaluating the effects of HMG -CoA reductase inhibitors on C -reactive protein, butyrylcholinesterase, and lipids
by: Shinn, Annie Heekyung
Published: (2004)

An Assessment of Oral Health in Hypertensive Patients Treated with HMG-CoA Reductase Inhibitors (Statins)
by: Amir AM Al-Joboury, et al.
Published: (2015-12-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
by: Noel Lorenzo Villalba, et al.
Published: (2021-06-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
by: Paolo Gelosa, et al.
Published: (2007-11-01)